Skip to main content

Table 1 Survey-adjusted, one-way frequencies of select variables

From: Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

Characteristic

Value

N

%

95% CI

Antimalarial category purchased

Chloroquine

468

9.0

7.9-10.2

ACT

1,109

21.4

19.1-23.8

Quinine

2,356

45.5

43.5-47.6

SP

661

12.8

11.6-14.0

Other antimalarial

110

2.1

1.6-2.7

Non-antimalarial

469

9.1

8.0-10.1

Had the shop at which the interview took place been supplied with subsidized ACT according to Surgipharm data?

Not supplied

4,146

80.1

77.3-83.0

 

Supplied

1,027

19.9

17.0-22.7

Age of the patient

<5 years

1,726

33.4

32.0-34.8

 

≥5 years

3,442

66.6

65.2-68.0

Age of the respondent

<20 years

767

15.0

13.9-16.1

20-29 years

2,156

41.7

40.4-43.1

30-39 years

1,502

29.1

27.9-30.2

 

≥40 years

732

14.2

13.2-15.1

Gender of the patient

Female

2,370

45.8

44.6-47.0

 

Male

2,803

54.2

53.0-55.4

Gender of the respondent

Female

2,581

49.9

48.4-51.3

 

Male

2,592

50.1

48.7-51.5

How long ago did symptoms begin?

<24 hours

2,862

57.0

54.9-59.0

24-48 hours

1,551

30.9

29.2-32.5

 

>48 hours

612

12.2

11.0-13.4

How long of a delay was there between onset of patient’s symptoms and initiation of any treatment?

<24 hours

3,221

64.0

61.9-66.1

24-48 hours

1,438

28.6

26.7-30.4

 

>48 hours

377

7.5

6.6-8.4

How long does it take the respondent to walk to the outlet at which the interview took place?

<15 minutes

2,223

43.1

41.1-45.1

15-29 minutes

1,898

36.8

35.1-38.5

30-59 minutes

860

16.7

15.2-18.1

1-1.9 hours

150

2.9

2.3-3.5

 

≥2 hours

31

0.6

0.3-0.8

How long does it take the respondent to walk to the nearest public health facility?

<15 minutes

685

13.3

11.8-14.8

15-29 minutes

1,471

28.6

26.6-30.5

30-59 minutes

2,014

39.1

36.9-41.4

1-1.9 hours

777

15.1

13.4-16.7

 

≥2 hours

199

3.9

3.0-4.8

What is the primary reason that the respondent selected this medicine?

Used it before

2,550

49.3

47.5-51.1

Recommended by health worker/seller

2,137

41.3

39.6-43.1

Only medicine available

210

4.1

3.2-4.9

Price

184

3.6

2.9-4.2

 

Other

91

1.8

1.4-2.1